Efficacy of Oral Alitretinoin in Treatment of Mycosis Fungoides Palmaris et Plantaris
DOI:
https://doi.org/10.2340/actadv.v103.18472Keywords:
Alitreitnoin, Retinoid, Mycosis fungoides, Mycosis fungoides palmaris et plantaris, Cutaneous T-cell lymphomaAbstract
Abstract is missing (Short communication)
Downloads
References
Kim ST, Jeon YS, Sim HJ, Kim SH, Kim YK, Suh KS, et al. Clinicopathologic features and T-cell receptor gene rearrangement findings of mycosis fungoides palmaris et plantaris. J Am Acad Dermatol 2006; 54: 466-471.
https://doi.org/10.1016/j.jaad.2005.11.1051 DOI: https://doi.org/10.1016/j.jaad.2005.11.1051
Dirschka T, Reich K, Bissonnette R, Maares J, Brown T, Diepgen TL. An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroids. Clin Exp Dermatol 2011; 36: 149-154.
https://doi.org/10.1111/j.1365-2230.2010.03955.x DOI: https://doi.org/10.1111/j.1365-2230.2010.03955.x
Ruzicka T, Lynde CW, Jemec GB, Diepgen T, Berth-Jones J, Coenraads PJ, et al. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol 2008; 158: 808-817.
https://doi.org/10.1111/j.1365-2133.2008.08487.x DOI: https://doi.org/10.1111/j.1365-2133.2008.08487.x
Kapser C, Herzinger T, Ruzicka T, Flaig M, Molin S. Treatment of cutaneous T-cell lymphoma with oral alitretinoin. J Eur Acad Dermatol Venereol 2015; 29: 783-788.
https://doi.org/10.1111/jdv.12684 DOI: https://doi.org/10.1111/jdv.12684
Alhusayen R, Vu TT, Almuhanna N, Wohlmuth-Wieser I, Hardin J, Hughes JM, et al. Evaluation of alitretinoin for the treatment of mycosis fungoides and Sézary syndrome. Dermatology 2021; 237: 479-485.
https://doi.org/10.1159/000512484 DOI: https://doi.org/10.1159/000512484
Kaemmerer T, Stadler PC, Helene Frommherz L, Guertler A, Einar French L, Reinholz M. Alitretinoin in the treatment of cutaneous T-cell lymphoma. Cancer Med. 2021; 10: 7071-7078.
https://doi.org/10.1002/cam4.4237 DOI: https://doi.org/10.1002/cam4.4237
Miernik B, Schmidt V, Technau-Hafsi K, Kern JS, Meiss F. Alitretinoin in the treatment of palmoplantar mycosis fungoides: a new and promising therapeutic approach. Clin Exp Dermatol 2015; 40: 445-447.
https://doi.org/10.1111/ced.12516 DOI: https://doi.org/10.1111/ced.12516
Pimpinelli N, Olsen EA, Santucci M, Vonderheid E, Haeffner AC, Stevens S, et al. Defining early mycosis fungoides. J Am Acad Dermatol 2005; 53: 1053-1063.
https://doi.org/10.1016/j.jaad.2005.08.057 DOI: https://doi.org/10.1016/j.jaad.2005.08.057
Stevens SR, Ke MS, Parry EJ, Mark J, Cooper KD. Quantifying skin disease burden in mycosis fungoides-type cutaneous T-cell lymphomas: the severity-weighted assessment tool (SWAT). Arch Dermatol 2002; 138: 42-48.
https://doi.org/10.1001/archderm.138.1.42 DOI: https://doi.org/10.1001/archderm.138.1.42
Cheng C, Michaels J, Scheinfeld N. Alitretinoin: a comprehensive review. Expert Opin Investig Drugs 2008; 17: 437-443.
https://doi.org/10.1517/13543784.17.3.437 DOI: https://doi.org/10.1517/13543784.17.3.437
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 Sun Mun Jeong, Seol Hwa Seong, Min Soo Jang, Kee Suck Suh, Jong Bin Park
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
